La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Brain (drug effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Brain (diagnostic imaging) < Brain (drug effects) < Brain (embryology)  Facettes :

List of bibliographic references indexed by Brain (drug effects)

Number of relevant bibliographic references: 31.
[0-20] [0 - 20][0 - 31][20-30][20-40]
Ident.Authors (with country if any)Title
000199 (2016) Thibaud Thiollier [France] ; Caisheng Wu ; Hugues Contamin [France] ; Qin Li [Royaume-Uni] ; Jinlan Zhang ; Erwan Bezard [France]Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.
000445 (2015) W. Peelaerts [Belgique] ; L. Bousset [France] ; A. Van Der Perren [Belgique] ; A. Moskalyuk [Belgique] ; R. Pulizzi [Belgique] ; M. Giugliano [Belgique] ; C. Van Den Haute [Belgique] ; R. Melki [France] ; V. Baekelandt [Belgique]α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.
000564 (2015) Gael Le Douaron [France] ; Fanny Schmidt [France] ; Majid Amar [France] ; Hanane Kadar [France] ; Lucila Debortoli [Brésil] ; Alexandra Latini [Brésil] ; Blandine Séon-Méniel [France] ; Laurent Ferrié [France] ; Patrick Pierre Michel [France] ; David Touboul [France] ; Alain Brunelle [France] ; Rita Raisman-Vozari [France] ; Bruno Figadère [France]Neuroprotective effects of a brain permeant 6-aminoquinoxaline derivative in cell culture conditions that model the loss of dopaminergic neurons in Parkinson disease.
000570 (2015) Audrey Maillet [France] ; Stéphane Thobois ; Valérie Fraix ; Jérôme Redouté ; Didier Le Bars ; Franck Lavenne ; Philippe Derost ; Franck Durif ; Bastiaan R. Bloem ; Paul Krack ; Pierre Pollak ; Bettina DebûNeural substrates of levodopa-responsive gait disorders and freezing in advanced Parkinson's disease: a kinesthetic imagery approach.
000573 (2015) H. Iderberg [Suède] ; A C Mccreary [Pays-Bas] ; M A Varney [États-Unis] ; M S Kleven [France] ; W. Koek [France] ; L. Bardin [France] ; R. Depoortère [France] ; M A Cenci [Suède] ; A. Newman-Tancredi [États-Unis]NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
000621 (2015) Carmen Noelker [Allemagne] ; Lixia Lu [France] ; Matthias Höllerhage [Allemagne] ; Franca Vulinovic [Allemagne] ; Annekathrin Sturn [Allemagne] ; René Roscher [Suisse] ; Günter U. Höglinger [Allemagne] ; Etienne C. Hirsch [France] ; Wolfgang H. Oertel [Allemagne] ; Daniel Alvarez-Fischer [Allemagne] ; Hartmann Andreas [France]Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease.
000723 (2015) Aude Gesquière-Dando [France] ; Eric Guedj [France] ; Anderson Loundou [France] ; Romain Carron [France] ; Tatiana Witjas [France] ; Frédérique Fluchère [France] ; Marie Delfini [France] ; Laura Mundler [France] ; Jean Regis [France] ; Jean-Philippe Azulay [France] ; Alexandre Eusebio [France]A preoperative metabolic marker of parkinsonian apathy following subthalamic nucleus stimulation.
000876 (2014) Mathieu Favier [France] ; Theo Duran ; Carole Carcenac ; Guillaume Drui ; Marc Savasta ; Sebastien CarnicellaPramipexole reverses Parkinson's disease-related motivational deficits in rats.
000A33 (2014) Franziska Richter [États-Unis] ; Fuying Gao [États-Unis] ; Vera Medvedeva [États-Unis] ; Patrick Lee [États-Unis] ; Nicholas Bove [États-Unis] ; Sheila M. Fleming [États-Unis] ; Magali Michaud [France] ; Vincent Lemesre [États-Unis] ; Stefano Patassini [États-Unis] ; Krystal De La Rosa [États-Unis] ; Caitlin K. Mulligan [États-Unis] ; Pedrom Sioshansi [États-Unis] ; Chunni Zhu [États-Unis] ; Giovanni Coppola [États-Unis] ; Thierry Bordet [France] ; Rebecca Pruss [France] ; Marie-Françoise Chesselet [États-Unis]Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons
000C03 (2013) Marie-France Nissou [France] ; Jacques Brocard ; Michèle El Atifi ; Audrey Guttin ; Annie Andrieux ; François Berger ; Jean-Paul Issartel ; Didier WionThe transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases.
000C83 (2013) S. Navailles [France] ; M. Lagière [France] ; A. Contini [France] ; P. De Deurwaerdère [France]Multisite Intracerebral Microdialysis to Study the Mechanism of L-DOPA Induced Dopamine and Serotonin Release in the Parkinsonian Brain
000D32 (2013) P. Péran [France] ; F. Nemmi ; D. Méligne ; D. Cardebat ; A. Peppe ; O. Rascol ; C. Caltagirone ; J F Demonet ; U. SabatiniEffect of levodopa on both verbal and motor representations of action in Parkinson's disease: a fMRI study.
000D39 (2013) Omar Ouachikh [France] ; Wisam Dieb ; Franck Durif ; Aziz HafidiDifferential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area.
000D96 (2013) Anne Buot [France] ; Marie-Laure Welter [France] ; Carine Karachi [France] ; Jean-Baptiste Pochon [France] ; Eric Bardinet [France] ; Jérôme Yelnik [France] ; Luc Mallet [France]Processing of emotional information in the human subthalamic nucleus
001225 (2012) Benedicte Ballanger [France] ; Helene Klinger [France] ; Julien Eche [France] ; Jérôme Lerond [France] ; Anne-Evelyne Vallet [France] ; Didier Le Bars [France] ; Leon Tremblay [France] ; Véronique Sgambato-Faure [France] ; Emmanuel Broussolle [France] ; Stéphane Thobois [France]Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease
001606 (2011) Sylvia Navailles [France] ; Bernard Bioulac ; Christian Gross ; Philippe De DeurwaerdèreChronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease.
001F53 (2009) Karim Farid [France] ; Igor Sibon ; Dominique Guehl ; Emmanuel Cuny ; Pierre Burbaud ; Michèle AllardBrain dopaminergic modulation associated with executive function in Parkinson's disease.
002288 (2008) Camille Brochier [France] ; Marie-Claude Gaillard ; Elsa Diguet ; Nicolas Caudy ; Carole Dossat ; Béatrice Ségurens ; Patrick Wincker ; Emmanuel Roze ; Jocelyne Caboche ; Philippe Hantraye ; Emmanuel Brouillet ; Jean-Marc Elalouf ; Michel De ChaldéeQuantitative gene expression profiling of mouse brain regions reveals differential transcripts conserved in human and affected in disease models.
002303 (2008) Daniel Alvarez-Fischer [France] ; Serge Guerreiro ; Stéphane Hunot ; Françoise Saurini ; Marc Marien ; Pierre Sokoloff ; Etienne C. Hirsch ; Andreas Hartmann ; Patrick P. MichelModelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid.
002320 (2008) Hervé Allain [France] ; Danièle Bentué-Ferrer ; Yvette AkwaDisease-modifying drugs and Parkinson's disease.
002914 (2006) Gilles Fénelon [France] ; Christopher G. Goetz ; Axel KarenbergHallucinations in Parkinson disease in the prelevodopa era.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Brain (drug effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Brain (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Brain (drug effects)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024